PD-1 INHIBITOR

Clinical trials for PD-1 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new PD-1 INHIBITOR trials appear

Sign up with your email to follow new studies for PD-1 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New triple therapy aims to boost esophageal cancer survival

Disease control Not yet recruiting

This study tests a new three-drug combination for people with advanced esophageal cancer. The drugs include a targeted therapy (becotatug vedotin), an immunotherapy (tislelizumab), and standard chemotherapy. The goal is to see if this combo shrinks tumors better than current trea…

Matched conditions: PD-1 INHIBITOR

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated May 17, 2026 06:23 UTC

PD-1 INHIBITOR

Get alerted when new PD-1 INHIBITOR trials appear

New triple therapy aims to boost esophageal cancer survival